Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
7,364
Total Claims
$737K
Drug Cost
614
Beneficiaries
$1,201
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-40%
Opioid rate vs peers
1.5% vs 2.6% avg
+12%
Cost per patient vs peers
$1,201 vs $1,068 avg
+30%
Brand preference vs peers
11.7% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.5%
Opioid Rate
114
Opioid Claims
$873
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 852 claims · $604K
Generic: 6,438 claims · $121K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Semaglutide | 60 | $71K |
| Apixaban | 69 | $64K |
| Dapagliflozin Propanediol | 61 | $59K |
| Rivaroxaban | 53 | $57K |
| Fluticasone/Umeclidin/Vilanter | 29 | $39K |
| Insulin Glargine,hum.Rec.Anlog | 44 | $33K |
| Denosumab | 19 | $32K |
| Dulaglutide | 22 | $29K |
| Budesonide/Glycopyr/Formoterol | 18 | $25K |
| Linaclotide | 23 | $20K |
| Sitagliptin Phosphate | 14 | $17K |
| Insulin Degludec | 16 | $8,410 |
| Evolocumab | 12 | $7,042 |
| Budesonide/Formoterol Fumarate | 17 | $7,036 |
| Levothyroxine Sodium | 216 | $5,881 |
Prescribing Profile
Patient Profile
73
Avg Age
66%
Female
1.10
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About